Herbal granules aim to lift mood in transplant survivors
NCT ID NCT07608029
First seen May 30, 2026 · Last updated Jun 19, 2026 · Updated 6 times
Summary
This study tests whether Xiaochaihu Granules, a traditional Chinese herbal medicine, can help with depression in people who have had a stem cell transplant. About 46 patients will receive either a low or high dose of the granules for 100 days, alongside standard care. Researchers will track mood changes, side effects, and transplant-related complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Xiaochaihu Granules (a traditional Chinese medicine herbal formula)
What this could lead to
If it works, this could offer a new option to ease depression in people recovering from a stem cell transplant, without adding strong side effects.
What could go wrong
This is a small, early-phase trial with only 46 people, so results may not apply widely. The herbal granules may not work better than standard care, and long-term safety is unknown.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.